GENOCEA BIOSCIENCES, INC. — Form D

GENOCEA BIOSCIENCES, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-03. The offering totals $79.9M, of which $75.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
KENNETH BATEDirectorCAMBRIDGE, MA
Ali BehbahaniDirectorLittleton, CO
KATRINE BOSLEYDirectorCAMBRIDGE, MA
RONALD COOPERDirectorCAMBRIDGE, MA
MICHAEL HIGGINSDirectorFRAMINGHAM, MA
Howard MayerDirectorWaltham, MA
GISELA SCHWABDirectorCAMBRIDGE, MA
George SiberDirectorIrvine, CA
GIRISH AAKALUExecutive OfficerCAMBRIDGE, MA
William ClarkExecutive OfficerAUSTIN, TX
Thomas DavisExecutive OfficerHAMILTON, D0
DIANTHA DUVALLExecutive OfficerCAMBRIDGE, MA
JESSICA FLECHTNERExecutive OfficerCAMBRIDGE, MA
Simeon GeorgeDirectorRedwood City, CA
Kevin BittermanDirectorCambridge, MA
Leon ChenDirectorAustin, TX
Stephen HoffmanDirectorVancouver, A1
Asish XavierDirectorSouth San Francisco, CA
Steve HoffmanDirectorReston, VA
Robert PaullDirectorBoston, MA
Narinder SinghExecutive OfficerOakland, CA
Derek MeisnerExecutive OfficerCambridge, MA
Michael AlfieriExecutive OfficerCambridge, MA
Pamela CarrollExecutive OfficerCambridge, MA
RAVI BAKER VENKATARAMANIExecutive OfficerCAMBRIDGE, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2019-02-27D$15.0M$12.1M
2013-10-10D$400K$400K
2013-07-02D/A$30.5M$30.5M
2012-10-11D$30.5M$15.3M
2011-01-03D$35.1M$35.1M

More